Suppr超能文献

亲水性蛋白质对淀粉样β聚集的荷电依赖性抑制作用。

Charge dependent retardation of amyloid β aggregation by hydrophilic proteins.

机构信息

Divisions of †Biochemistry and Structural Biology and ‡Biophysical Chemistry, Lund University , P.O. Box 124, SE 221 00 Lund, Sweden.

出版信息

ACS Chem Neurosci. 2014 Apr 16;5(4):266-74. doi: 10.1021/cn400124r. Epub 2014 Feb 6.

Abstract

The aggregation of amyloid β peptides (Aβ) into amyloid fibrils is implicated in the pathology of Alzheimer's disease. In light of the increasing number of proteins reported to retard Aβ fibril formation, we investigated the influence of small hydrophilic model proteins of different charge on Aβ aggregation kinetics and their interaction with Aβ. We followed the amyloid fibril formation of Aβ40 and Aβ42 using thioflavin T fluorescence in the presence of six charge variants of calbindin D9k and single-chain monellin. The formation of fibrils was verified with transmission electron microscopy. We observe retardation of the aggregation process from proteins with net charge +8, +2, -2, and -4, whereas no effect is observed for proteins with net charge of -6 and -8. The single-chain monellin mutant with the highest net charge, scMN+8, has the largest retarding effect on the amyloid fibril formation process, which is noticeably delayed at as low as a 0.01:1 scMN+8 to Aβ40 molar ratio. scMN+8 is also the mutant with the fastest association to Aβ40 as detected by surface plasmon resonance, although all retarding variants of calbindin D9k and single-chain monellin bind to Aβ40.

摘要

淀粉样β肽(Aβ)的聚集形成淀粉样纤维与阿尔茨海默病的病理学有关。鉴于越来越多的蛋白质被报道能延缓 Aβ 纤维的形成,我们研究了不同电荷的小亲水性模型蛋白对 Aβ 聚集动力学及其与 Aβ相互作用的影响。我们使用硫黄素 T 荧光法,在 6 种钙结合蛋白 D9k 的电荷变体和单链莫内林的存在下,跟踪 Aβ40 和 Aβ42 的淀粉样纤维形成。用透射电子显微镜验证了纤维的形成。我们观察到带净正电荷+8、+2、-2 和-4 的蛋白质会延缓聚集过程,而带净负电荷-6 和-8 的蛋白质则没有影响。带有最高净电荷+8 的单链莫内林突变体对淀粉样纤维形成过程的延缓作用最大,即使在 Aβ40 与 scMN+8 的摩尔比低至 0.01:1 时,也明显延迟。scMN+8 也是通过表面等离子体共振检测到与 Aβ40 结合最快的突变体,尽管所有钙结合蛋白 D9k 和单链莫内林的延缓变体都与 Aβ40 结合。

相似文献

1
Charge dependent retardation of amyloid β aggregation by hydrophilic proteins.
ACS Chem Neurosci. 2014 Apr 16;5(4):266-74. doi: 10.1021/cn400124r. Epub 2014 Feb 6.
2
A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
J Struct Biol. 2016 Apr;194(1):61-7. doi: 10.1016/j.jsb.2016.01.013. Epub 2016 Jan 28.
3
Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
Biomolecules. 2021 Jan 30;11(2):198. doi: 10.3390/biom11020198.
4
Ionic Strength Modulation of the Free Energy Landscape of Aβ40 Peptide Fibril Formation.
J Am Chem Soc. 2016 Jun 1;138(21):6893-902. doi: 10.1021/jacs.6b04511. Epub 2016 May 23.
5
Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.
J Neurochem. 2013 Aug;126(3):305-11. doi: 10.1111/jnc.12202. Epub 2013 Mar 12.
6
Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5407-12. doi: 10.1073/pnas.1421961112. Epub 2015 Mar 30.
7
Static and dynamic disorder in Aβ40 fibrils.
Biochem Biophys Res Commun. 2022 Jun 25;610:107-112. doi: 10.1016/j.bbrc.2022.04.036. Epub 2022 Apr 15.
8
Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation.
J Biol Chem. 2003 Jun 27;278(26):23648-55. doi: 10.1074/jbc.M212785200. Epub 2003 Apr 25.
9
Structural origin of polymorphism of Alzheimer's amyloid β-fibrils.
Biochem J. 2012 Oct 1;447(1):43-50. doi: 10.1042/BJ20120034.

引用本文的文献

3
The unhappy chaperone.
QRB Discov. 2021 Jul 8;2:e7. doi: 10.1017/qrd.2021.5. eCollection 2021.
4
Nanomedicines in the Management of Alzheimer's Disease: Current View and Future Prospects.
Front Aging Neurosci. 2022 Jul 8;14:879114. doi: 10.3389/fnagi.2022.879114. eCollection 2022.
5
Cell-Penetrating Peptides with Unexpected Anti-Amyloid Properties.
Pharmaceutics. 2022 Apr 9;14(4):823. doi: 10.3390/pharmaceutics14040823.
6
Linking Alzheimer's Disease and Type 2 Diabetes: Characterization and Inhibition of Cytotoxic Aβ and IAPP Hetero-Aggregates.
Front Mol Biosci. 2022 Mar 17;9:842582. doi: 10.3389/fmolb.2022.842582. eCollection 2022.
7
The amyloid-inhibiting NCAM-PrP peptide targets Aβ peptide aggregation in membrane-mimetic environments.
iScience. 2021 Jul 10;24(8):102852. doi: 10.1016/j.isci.2021.102852. eCollection 2021 Aug 20.
8
Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer's Disease.
Molecules. 2020 Oct 21;25(20):4866. doi: 10.3390/molecules25204866.
9
The Amphipathic GM1 Molecule Stabilizes Amyloid Aggregates, Preventing their Cytotoxicity.
Biophys J. 2020 Jul 21;119(2):326-336. doi: 10.1016/j.bpj.2020.06.005. Epub 2020 Jun 12.
10
Complete aggregation pathway of amyloid β (1-40) and (1-42) resolved on an atomically clean interface.
Sci Adv. 2020 Apr 8;6(15):eaaz6014. doi: 10.1126/sciadv.aaz6014. eCollection 2020 Apr.

本文引用的文献

1
Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides.
Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9384-9. doi: 10.1073/pnas.1401564111. Epub 2014 Jun 17.
2
Human lysozyme inhibits the in vitro aggregation of Aβ peptides, which in vivo are associated with Alzheimer's disease.
Chem Commun (Camb). 2013 Jul 25;49(58):6507-9. doi: 10.1039/c3cc42325e. Epub 2013 Jun 13.
3
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9758-63. doi: 10.1073/pnas.1218402110. Epub 2013 May 23.
4
Cellular polyamines promote amyloid-beta (Aβ) peptide fibrillation and modulate the aggregation pathways.
ACS Chem Neurosci. 2013 Mar 20;4(3):454-62. doi: 10.1021/cn300170x. Epub 2013 Jan 16.
5
Amyloid-β peptide binds to cytochrome C oxidase subunit 1.
PLoS One. 2012;7(8):e42344. doi: 10.1371/journal.pone.0042344. Epub 2012 Aug 21.
7
A mobile precursor determines amyloid-β peptide fibril formation at interfaces.
J Am Chem Soc. 2012 Aug 29;134(34):14172-8. doi: 10.1021/ja305398f. Epub 2012 Aug 17.
8
BRICHOS domains efficiently delay fibrillation of amyloid β-peptide.
J Biol Chem. 2012 Sep 7;287(37):31608-17. doi: 10.1074/jbc.M112.393157. Epub 2012 Jul 16.
9
Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation.
ACS Chem Neurosci. 2010 Apr 21;1(4):279-87. doi: 10.1021/cn900027u. Epub 2010 Jan 27.
10
Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process.
ACS Chem Neurosci. 2010 Jan 20;1(1):13-8. doi: 10.1021/cn900015v. Epub 2009 Oct 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验